If you were to be an investor in SEGI it does not matter

New Post Public Reply Private Reply Replies (0) Message Board
RyGuy

If you were to be an investor in SEGI it does not matter what the film investors make, it matters what the distributors take is. Film Producers have a larger risk of losing money on a film, than Distributors do. Distributors are last money in the investment flow of a film and first money out. Aside from the theater chains. 

Every distribution deal is in effect a operating business of its own. But you can use base percentages and get a decent estimation of what a company like SEGI could potentially earn from distribution. They also will make money from managing the P&A fund. Here is the article from last year discussing that P&A fund. 

http://www.fa-mag.com/component/content/artic...Itemid=211  

I will use low end numbers in these estimations because most full service distributors actually make at least 30% but my number is based on a low end service deal of 15%, much like what Freestyle Releasing normally receives. However Sycamore says potential for 45% on their website. 

http://www.sycamoreentertainment.com/entertai...rvices.php  

Quote:
DISTRIBUTION PROCESS / 

Sycamore acquires all North American rights for quality specialty independent movies (indie, art, foreign language and lower budget) and releases these titles into all media formats. 
Potential films can be sourced through film festivals, independent producers, and international film commissions. 
In exchange for all North American rights, Sycamore can be responsible for  P&A funds and 45% of all net profits.  
The business model is designed so that Sycamore’s P&A investment will be repaid in full before the participation percentage is paid.



Every deal is different, but P&A (Print & Advertising) funds gets paid back first after the theatrical run 50/50 split with the theater chains. Then distributors make anywhere from 15% to 40% off of their 50% take in gross revenues. 

So just as an example. Using the film "Insidious", and just pretending that Sycamore acquired the distribution rights to that film. Again this is just pretending that Sycamore Entertainment released "Insidious" because obviously they did not. 

In our example SEGI would have successfully released the film domestically to the tune of $54 Million. They would split that $54 on average with the Theaters and take a cut of $27 Million. 

Now the Print and Advertising fund they used has to be paid from the $27 Million. Lets assume a $10 Million P&A fund was used for the film which is probably a bit high. Film prints and delivery cost an average of approximately $1000 for each theater location, and as low as $200 for delivery of digital media and then associated advertising for a few weeks prior. I'm assuming P&A was probably around $5 to $7.5 Million. But $10 Million should be a safe barometer. 

http://www.boxofficemojo.com/movies/?id=insidious.htm  

We subtract the $10 Million P/A and we'll say a $2.5 Million fee or $25% profit to pay the P&A fund investors that Sycamore Manages for a total of $12.5 Million taken from that $27 Million theater split figure. 

We now have a total of $14.5 Million gross from which distributors are allowed to take any incurred expenses as well as their agreed upon distribution fee which can be anywhere from 15% to 40% but we will use 15% on the low end which is essentially the equivalence of a "service deal". 

So say there were $2 Million in expenses negotiated in management fees with the films distribution such as distribution management, marketing plans, and marketing consultants that Sycamore could take off the top to pay off those expenses leaving $12.5 Million. Then there is the 15% SEGI could potentially bring in as their distribution fee which could net them $1,875,000 from the remaining $12,500,000 in this instance plus say a P&A managment fee of $500K, thus leaving the producers that made "Insidious" with $10,625,000 to cover their production budget of $1.5 Million and making the producers a $9,125,000 Million profit. 

Take into account the monies made by SEGI in Distribution Fees of $2,000,000 and their 15% take of 1,875,000 and their P&A management of $500,000 then there is potential for $4,375,000 in Revenues from 1 successful film. 

If just $1,000,000 of this is profit (low end) and they can replicate this business across 5-8 films a year then a significant return could be foreseen. Use 5 films and $5 Million in profit annually from those films spread across an O/S of 177 Million give and EPS of $.028 

Use a low end P/E ratio of 10 and you have a $.28 stock. Use a 20 P/E and you have a $.56 stock. 

Get a couple of movies that have success comparable to "The King's Speech" and Sycamore becomes the next Lionsgate or Summit on the distribution depth chart and your looking at a moon shot of the share price. 

Keep in mind, that I did not mention anything about the monies received from Home and Video distribution. A DVD costs distributors on average about $1 to produce from a 3rd Party supplier. If walmart sells a DVD for $15 the price paid to SEGI would probably be around $7.50. Minus $1 production run costs there is $6.50 left to split between film producers and SEGI the distributor. SEGI would get approximately 40% of that cut as distributor or $2.60 per DVD. 

1 Million DVD's sold would net them $2.6 Million based on that calculation. 

Even a moderately successful film the makes $5 to $10 Million in a theatrical run, which is probably where our bread and butter lies, will provide significant revenues for SEGI. 

Say a $5 Million dollar film using all the above examples but on a lower scale, would probably see a theatrical run of maybe a high of 500 theaters. Say $700K P&A used and there would be $1.8 Million to take their cut from. At 30% they could be looking at a $540,000 cut from the theatrical take and possibly another $200,000 in management fees. Do this 5 times a year targeting decent films and they could have $3,750,000 in revenues and say $1 Million in profits. Each one of those 5 films sells 50,000 DVD's multiplied by $2.60 average DVD profit is $130,000. Times 5 movies that is $650K. 

Combine theater and DVD profits that could be $1,650,000 and divided across 177 million O/S shares you get an EPS of $.009. Using the same low end P/E multiple of 10 and you have a 9 cent stock. 20 P/E and you would have an 18 cent stock. 

If they continually target quality films like "The Eye of the Storm" that has talks of potential for Academny Awards, then these numbers are not out of the realm of possibility. 

Am I saying this will happen. Of course not, but I believe I used some very low numbers to portray the possibilities here. 

Just so you know Judy Davis has already been nominated for an Academy Award in Australia for her performance in "The Eye of the Storm" There is talk circling that she and Geoffrey could be nominated for their performances here in the U.S. also. 

Make your decision. If by some chance the O/S has not changed and this is traders creating this drop, then SEGI is unbelievably cheap. 

Sycamore Entertainment Group Inc. (SEGI) Stock Research Links

SEGI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Major Refinancing Deal in Multifamily Sector by Newmark Group

Updated Category News Views 168

Newmark Group Secures $690 Million for West Shore Portfolio Newmark Group, Inc. (NASDAQ: NMRK), a prominent name in commercial real estate advisory, has successfully arranged a substantial $690 million loan aimed at refinancing a diverse collection of 13 multifamily properties owned by West Shore. These properties are located in several states, including vibrant areas...

Continue Reading
MassageLuXe Expands Its Relaxation Services in Grand Rapids

Updated Category News Views 193

MassageLuXe Expands Its Relaxation Services in Grand Rapids MassageLuXe, a leading spa franchise known for its exceptional massage, facial, and waxing services, is gearing up to enhance wellness offerings in the Grand Rapids area. This strategic initiative marks the company's intent to further establish its footprint in Michigan's second-largest city, driven by the...

Continue Reading
Taylor Heise Joins Upper Deck: A Milestone in Women's Sports

Updated Category News Views 454

Taylor Heise Joins Upper Deck's Elite Team of Athletes Leading the charge in the realm of sports collectibles, Upper Deck recently announced an exciting partnership with Taylor Heise, a standout player in the Professional Women's Hockey League (PWHL). This collaboration highlights the growing prominence of women athletes in sports collectibles, specifically with Heise,...

Continue Reading
Eminent Gold Strengthens Team with Ivan Bebek's Expertise

Updated Category News Views 81

Eminent Gold Welcomes Ivan Bebek as Strategic Advisor Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) is making headlines with the recent appointment of Ivan Bebek as a Strategic Advisor for Corporate Development and Finance. This strategic move aims to bolster the company's efforts in identifying and advancing new gold discoveries in Nevada. Ivan Bebek: A Wealth of...

Continue Reading
B. Riley Financial Plans Hearing for Nasdaq Compliance Status

Updated Category News Views 167

Understanding B. Riley Financial's Nasdaq Situation B. Riley Financial, Inc. (Nasdaq: RILY) has announced a significant event regarding its listing status on the Nasdaq exchange. The company received a Staff Determination Letter from the Nasdaq Listing Qualifications Staff, pointing out non-compliance issues that date back to earlier notifications. These notifications...

Continue Reading